HISTOPATHOLOGICAL AND IMMUNOPHENOTYPIC CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: A MULTICENTER STUDY AND LITERATURE REVIEW

Vũ Quý Nguyễn, Hoàng Minh Đặng, Anh Tú Thái, Đình Thế Nguyên Trịnh , Đặng Anh Thư Phan

Main Article Content

Abstract

Background: Anaplastic large cell lymphoma (ALCL) with ALK positivity is a distinct subtype of T-cell lymphoma, typically occurring in younger patients and characterized by heterogeneous histologic patterns and immunophenotypic profiles. Describing the histopathological and immunohistochemical features of ALK-positive ALCL contributes to diagnostic accuracy and therapeutic orientation. This study aimed to evaluate the histologic characteristics and immunophenotypic expression patterns of ALK-positive ALCL cases diagnosed at medical institutions in Ho Chi Minh City. Methods: A descriptive case series was conducted on patients diagnosed with ALK-positive ALCL between January 2020 and January 2025 at Ho Chi Minh City Oncology Hospital, Children’s Hospital No.1, and the Department of Embryology, Histology, and Pathology, University of Medicine and Pharmacy at Ho Chi Minh City. Results: A total of 38 cases were recorded. The mean age in the pediatric group (<16 years) was 8.2 ± 3.8 years, while in the adolescent/adult group (≥16 years) it was 27 years, with a male-to-female ratio of 1,2:1. Nodal involvement accounted for 68.4% and extranodal lesions for 31.6%. The histologic subtypes included classic (76.3%), lymphohistiocytic (13.2%), small-cell (7.9%), and other variants (2.6%). Regarding immunophenotype, ALK-1 staining showed both nuclear and cytoplasmic expression in 78.9% of cases and cytoplasmic-only expression in 21.1%. Positivity rates for T-cell lineage markers were CD2 (31.6%), CD3 (36.1%), CD5 (52.4%), CD45 (84.6%), and EMA (84.2%). EMA expression was predominantly focal (<25% of tumor cells) in 50% of cases. Conclusion: ALK-positive ALCL predominantly affects patients within the first three decades of life, with nodal involvement being most common and the classic subtype representing the majority of cases. ALK-1 expression is mainly nuclear and cytoplasmic. CD45 and EMA show high positivity rates and are useful adjunctive markers in diagnosis. Notably, EMA expression was mostly focal, differing from previous reports in the literature.

Article Details

References

1. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. Mar 15 1998;91(6):2076-84
2. Elenitoba JK, Ott G, Takeuchi K, et al. ALK-positive anaplastic large cell lymphoma. IARC. Accessed July, 6th, 2025. https://tumourclassification.iarc.who.int/chaptercontent/63/232
3. Hsi ED, Said J, Macon WR, et al. Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project. Am J Surg Pathol. 2014 Jun;38(6):768-75.
4. Huang S, Yang X, Duan Y, et al. Clinical Pathology Characteristics of 221 Pediatric Anaplastic Large Cell Lymphoma-3 Years Follow up and Experience from China Net Childhood Lymphoma(CNCL). Blood. Nov 2023;142:4489
5. Khanlari M, Li S, Miranda RN, et al. Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma. Modern Pathology. 2022 Mar;35(3):412-418.
6. Lamant RL, d'Amore ESG, Nakazawa A, et al. ALK-positive anaplastic large cell lymphoma. IARC. Accessed July, 6th, 2025. https://tumourclassification.iarc.who.int/chaptercontent/44/57
7. Mark E, Sutton M, Gru A. Primary Cutaneous Anaplastic Large-Cell Lymphoma With Aberrant CD20 Expression: Case Report and Review of the Literature. The American Journal of dermatopathology. Dec 2022;44(12):971-978
8. ten Berge RL, Snijdewint FG, von Mensdorff-Pouilly S, et al. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. Journal of clinical pathology. Dec 2001;54(12):933-9.